134380.KS
Miwon Chemicals Co., Ltd.
KSC · Basic Materials · Chemicals · KR
KRW 10,350.00
+0.39%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 342.0B | 284.5B | 256.1B | 232.6B | 235.2B |
| Cost of Revenue | 272.4B | 233.3B | 207.6B | 190.4B | 199.4B |
| Gross Profit | 69.6B | 51.2B | 48.5B | 42.2B | 35.8B |
| Operating Expenses | |||||
| R&D Expense | 1.2B | 1.1B | 1.2B | 884.4M | 979.5M |
| SG&A Expense | 19.6B | 15.2B | 13.9B | 12.3B | 11.9B |
| General & Admin Expense | 457.2M | 617.1M | 640.6M | 528.7M | 414.1M |
| Selling & Marketing Expense | 11.8B | 14.6B | 13.2B | 11.7B | 11.5B |
| Other Expenses | 1.9B | 5.7B | 4.8B | 3.9B | 4.0B |
| Total Operating Expenses | 22.3B | 22.1B | 19.8B | 17.0B | 16.8B |
| Cost and Expenses | 294.7B | 255.4B | 227.5B | 207.7B | 216.2B |
| Operating Income (EBIT) | 47.3B | 29.2B | 28.6B | 24.9B | 19.0B |
| Non-Operating | |||||
| Interest Income | 2.0B | 2.0B | 1.9B | 1.1B | 383.6M |
| Interest Expense | — | — | — | 22.0K | 276.0K |
| Net Interest Income | 2.0B | 2.0B | 1.9B | 1.1B | 383.3M |
| Other Non-Op Income/Expense | 5.4B | 1.8B | 5.5B | 2.1B | 2.0B |
| Non-Operating Income (excl Interest) | — | — | 317.9M | (1.9B) | (2.1B) |
| EBT (Pre-Tax Income) | 52.6B | 31.0B | 34.1B | 27.0B | 20.9B |
| Income Tax Expense | 11.5B | 6.3B | 7.2B | 5.2B | 4.7B |
| Bottom Line | |||||
| Net Income | 41.1B | 24.7B | 26.9B | 21.8B | 16.3B |
| Earnings from Cont. Ops | 41.1B | 24.7B | 26.8B | 21.8B | 16.3B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 41.1B | 24.7B | 26.9B | 21.8B | 16.3B |
| Per Share | |||||
| Basic EPS | ₩1,517 | ₩1,235 | ₩134 | ₩108 | ₩80 |
| Diluted EPS | ₩1,515 | ₩1,235 | ₩134 | ₩108 | ₩80 |
| Revenue Per Share | ₩17,640 | ₩1,420 | ₩1,279 | ₩1,148 | ₩1,151 |
| Shares | |||||
| Basic Shares Outstanding | 19.4M | 200.3M | 200.3M | 202.7M | 204.3M |
| Diluted Shares Outstanding | 19.4M | 200.3M | 200.3M | 202.7M | 204.3M |
| Profitability Metrics | |||||
| EBITDA | 60.4B | 42.8B | 41.7B | 40.3B | 32.6B |
| D&A | 13.1B | 13.7B | 13.1B | 13.4B | 11.5B |
| EBIT | 47.3B | 29.2B | 28.6B | 26.8B | 21.1B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026